Cargando…

The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders

Detalles Bibliográficos
Autores principales: König, Alexandra, Sacco, Guillaume, Bensadoun, Gregory, Bremond, Francois, David, Renaud, Verhey, Frans, Aalten, Pauline, Robert, Philippe, Manera, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460798/
https://www.ncbi.nlm.nih.gov/pubmed/26106324
http://dx.doi.org/10.3389/fnagi.2015.00110
_version_ 1782375437922467840
author König, Alexandra
Sacco, Guillaume
Bensadoun, Gregory
Bremond, Francois
David, Renaud
Verhey, Frans
Aalten, Pauline
Robert, Philippe
Manera, Valeria
author_facet König, Alexandra
Sacco, Guillaume
Bensadoun, Gregory
Bremond, Francois
David, Renaud
Verhey, Frans
Aalten, Pauline
Robert, Philippe
Manera, Valeria
author_sort König, Alexandra
collection PubMed
description
format Online
Article
Text
id pubmed-4460798
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-44607982015-06-23 The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders König, Alexandra Sacco, Guillaume Bensadoun, Gregory Bremond, Francois David, Renaud Verhey, Frans Aalten, Pauline Robert, Philippe Manera, Valeria Front Aging Neurosci Neuroscience Frontiers Media S.A. 2015-06-09 /pmc/articles/PMC4460798/ /pubmed/26106324 http://dx.doi.org/10.3389/fnagi.2015.00110 Text en Copyright © 2015 König, Sacco, Bensadoun, Bremond, David, Verhey, Aalten, Robert and Manera. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
König, Alexandra
Sacco, Guillaume
Bensadoun, Gregory
Bremond, Francois
David, Renaud
Verhey, Frans
Aalten, Pauline
Robert, Philippe
Manera, Valeria
The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
title The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
title_full The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
title_fullStr The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
title_full_unstemmed The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
title_short The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
title_sort role of information and communication technologies in clinical trials with patients with alzheimer’s disease and related disorders
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460798/
https://www.ncbi.nlm.nih.gov/pubmed/26106324
http://dx.doi.org/10.3389/fnagi.2015.00110
work_keys_str_mv AT konigalexandra theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT saccoguillaume theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT bensadoungregory theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT bremondfrancois theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT davidrenaud theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT verheyfrans theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT aaltenpauline theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT robertphilippe theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT maneravaleria theroleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT konigalexandra roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT saccoguillaume roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT bensadoungregory roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT bremondfrancois roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT davidrenaud roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT verheyfrans roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT aaltenpauline roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT robertphilippe roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders
AT maneravaleria roleofinformationandcommunicationtechnologiesinclinicaltrialswithpatientswithalzheimersdiseaseandrelateddisorders